Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study. - Gossec, Laure; Baraliakos, Xenofon; Galloway, James; Oke, Vilija; Sfikakis, Petros; Rampakakis, Emmanouil; Sharaf, Mohamed; Lavie, Frederic; McInnes, Iain B. (Rheumatology & Therapy, 2026)